Search results for: Pricing and Reimbursement

Caring about Carers: Improving Consideration of the Burden of Informal Caring in HTA

11 April 2023

…can lead to substantively different results and recommendations that could undermine access to new technologies that could improve patient and carer outcomes. To address these challenges, and appropriately value the…

Measuring and Valuing Outcomes

Measuring and Valuing Outcomes We conduct applied and methodological research to identify and understand the outcomes that matter to patients, carers, and/or society, the value they assign to those outcomes,…

Dr. Sabine Vogler

4 September 2024

…European countries with regard to pharmaceutical pricing / prices, reimbursement, procurement and distribution. Sabine Vogler coordinated numerous research projects at national and European levels and was pivotal in establishing the…

OHE at the ISPOR Summit on New Approaches to Value Assessment: Towards More Informed Pricing in Healthcare October, 2018

5 November 2018

…Nancy Devlin, OHE Visting Senior Research Fellow Lou Garrison and Patricia Danzon, of the Wharton School and a member of OHE’s Research and Policy Committee presented at the ISPOR Summit…

Approaches, Challenges and Successful Stories of Multi-indication Pricing in Europe

28 November 2018

Multi-Indication Pricing: Practical Solutions and Steps to Move Forward. A summary of an HTAi panel session. We have just published a new OHE Briefing entitled ‘Multi-Indication Pricing: Practical Solutions and…

Victor R. Fuchs Award for 2020 Goes to Patricia Danzon

23 June 2020

…and Pereira, 2005) and ‘Biotech-Pharma Alliances as a Signal of Asset and Firm Quality’ (Nicholson, Danzon and McCulloch, 2005). However, it is her contribution to biopharmaceutical pricing that is perhaps…

Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution?

1 February 2011

This paper examines the potentially positive impact of differential pricing in Europe and the overall negative effects of international reference pricing (IRP) measures. The authors point out that IRP actually…

Dilek Sernur Eminoğulları

26 January 2024

…policy formulation regarding pharmaceutical reimbursement, economic evaluation of drugs applying for reimbursement, drafting alternative reimbursement agreements, analysis of innovative pharmaceutical pricing and reimbursement models. She took active role in the…

Exploring the Financial Sustainability of Gene Therapies

5 January 2021

…Towse, A., Graf von der Schulenburg, J.M. and Wong, O. 2018. Advanced Therapy Medicinal Products and Health Technology Assessment Principles and Practices for Value-based and Sustainable Healthcare, T he European…